Epidemiology and Possible Causes of Autism

Pharmacotherapy

Volumn 23, Issue 12 I, 2003, Pages 1524-1530

  Jick, Hershel ^a   Kaye, James A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Epidemiology; MMR vaccine

Indexed keywords

ANTIDEPRESSANT AGENT; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FOLIC ACID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IRON; MEASLES MUMPS RUBELLA VACCINE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL POLIOMYELITIS VACCINE;

AUTISM; CLINICAL PRACTICE; DEVELOPMENTAL DISORDER; DIAGNOSTIC TEST; HUMAN; IMMUNIZATION; INCIDENCE; POPULATION RESEARCH; PRENATAL DRUG EXPOSURE; REVIEW; RISK ASSESSMENT; SENSORY DYSFUNCTION;

AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MEASLES-MUMPS-RUBELLA VACCINE; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 0345570516     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.15.1524.31955     Document Type: Review

References (17)

1. Phillips M. MMR: the truth. In: UK Daily Mail, London, March 11-13, 2003:10.
2. Fitzpatrick M. MMR: the truth? Available from http://www. spiked-online.com/articles/00000006DCD6.htm. Accessed September 15, 2003.
3. United Kingdom Medical Research Council. MRC review of autism research: epidemiology and causes. December 2001. Available [rom http://www.mrc.ac.uk/pdf-autism-report.pdf. Accessed September 15, 2003.
4. Last JM, Spasoff RA, Harris SS, Thuriauz MC, ed. A dictionary of epidemiology, 4th ed. New York: Oxford University Press, 2001.
5. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-41.
6. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026-9.
7. Wakefield AJ. MMR vaccination and autism [letter]. Lancet 1999;354:949-50.
8. Kaye JA, Melero-Montes MM, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time-trend analysis. BMJ 2001;322:460-3.
9. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. The validity of the general practice research database. Pharmacotherapy 2003;23:686-9.
10. Black C, Kaye JA, Jick H. Relation of childhood gastrointestinal disorders to autism: a nested case-control study in the UK general practice research database. BMJ 2002;325:419-21.
11. Dales L, Hammer SJ, Smith NJ. Time trends in autism and MMR immunization coverage in California. JAMA 2001;285:1183-5.
12. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002;347:1477-82.
13. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of autism in a US metropolitan area. JAMA 2003;289:49-55.
14. Jick H, Kaye JA, Black C. Changes in risk of autism in the U.K. for birth cohorts 1990-1998. Epidemiology 2003;14(5):431-2.
15. Croen LA, Grether JK, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Dev Disord 2002;32:207-15.
16. Lamb JA, Moore J, Bailey A, Monaco AP. Autism: recent molecular genetic advances. Hum Mol Genet 2000;9:861-8.
17. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77.